PALATINE, Ill., July 30, 2009 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) (the "Company") today reported a second quarter 2009 net loss of $6.5 million, or $0.14 per share compared to net income of $6.9 million, or $0.13 per diluted share for the second quarter of 2008. For the six months ending June 30, 2009, the Company reported a net loss of $7.8 million, or $0.17 per share compared to net income of $14.3 million, or $0.28 per diluted share for the same period in 2008. As of July 29, 2009, we had cash and cash equivalents of approximately $34.5 million with no term indebtedness.
